<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Check-cap Ltd. — News on 6ix</title>
<link>https://6ix.com/company/check-cap-ltd-1</link>
<description>Latest news and press releases for Check-cap Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 24 Feb 2026 13:35:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/check-cap-ltd-1" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d768de51cc36e47533bb93.webp</url>
<title>Check-cap Ltd.</title>
<link>https://6ix.com/company/check-cap-ltd-1</link>
</image>
<item>
<title>MBody AI and Check Cap Ltd. ($MBAI) Submit Nasdaq Listing Application for Merger Close</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/mbody-ai-and-check-cap-ltd-dollarmbai-submit-nasdaq-listing-application-for-merger-close</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/mbody-ai-and-check-cap-ltd-dollarmbai-submit-nasdaq-listing-application-for-merger-close</guid>
<pubDate>Tue, 24 Feb 2026 13:35:00 GMT</pubDate>
<description>Proposed Nasdaq-listed AI company achieves key regulatory milestone as merger with Check-Cap targets first half of 2026; $30M growth facility availableISFIYA, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ: MBAI) (“Check-Cap” or the “Company”), a Nasdaq-listed company, today announced that MBody AI Corp. (“MBody AI”) has submitted its Nasdaq listing application, representing a significant regulatory milestone toward closing the previously announced merger between Check-Cap and</description>
</item>
<item>
<title>Check-Cap Advances MBody AI Merger with F-1 Filing and MBody AI Audited Financials</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-advances-mbody-ai-merger-with-f-1-filing-and-mbody-ai-audited-financials</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-advances-mbody-ai-merger-with-f-1-filing-and-mbody-ai-audited-financials</guid>
<pubDate>Mon, 02 Feb 2026 05:00:00 GMT</pubDate>
<description>Company Confirms Merger with MBody AI Remains on Track following regaining Compliance with NASDAQ Listing Standards; Provides Update Regarding Recently Filed</description>
</item>
<item>
<title>MBody AI to Begin Trading Under New NASDAQ Ticker Symbol "MBAI" $MBAI</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/mbody-ai-to-begin-trading-under-new-nasdaq-ticker-symbol-mbai-dollarmbai</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/mbody-ai-to-begin-trading-under-new-nasdaq-ticker-symbol-mbai-dollarmbai</guid>
<pubDate>Mon, 01 Dec 2025 13:35:00 GMT</pubDate>
<description>Ticker change for Check-Cap's ($MBAI) transformation into a publicly traded embodied-AI company and ongoing strategy to scale enterprise automation with a hardware-agnostic AI platform.Las Vegas, Nevada and Isfiya, Israel--(Newsfile Corp. - December 1, 2025) - MBody AI Corp. ("MBody AI"), and Check-Cap Ltd. (NASDAQ: MBAI) (the "Company"), today announced that its Nasdaq ticker symbol will change from "CHEK" ($CHEK) to "MBAI" ($MBAI), effective at the opening of trading December 2, 2025. The new.</description>
</item>
<item>
<title>Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-third-quarter-2023-financial-results-and-provides-a-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-third-quarter-2023-financial-results-and-provides-a-corporate-update</guid>
<pubDate>Mon, 27 Nov 2023 05:00:00 GMT</pubDate>
<description>Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual General Meeting on Monday, December 18th ISFIYA,</description>
</item>
<item>
<title>Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-issues-letter-to-shareholders-regarding-proposed-merger-with-keystone-dental-holdings</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-issues-letter-to-shareholders-regarding-proposed-merger-with-keystone-dental-holdings</guid>
<pubDate>Thu, 19 Oct 2023 04:00:00 GMT</pubDate>
<description>ISFYIA, Israel, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), today issued the following letter from its</description>
</item>
<item>
<title>Check-Cap Reports Second Quarter 2023 Financial Results</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-second-quarter-2023-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-second-quarter-2023-financial-results</guid>
<pubDate>Fri, 04 Aug 2023 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, Aug. 4, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial results for the second</description>
</item>
<item>
<title>Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-review-of-strategic-alternatives-and-reduction-in-workforce</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-review-of-strategic-alternatives-and-reduction-in-workforce</guid>
<pubDate>Tue, 06 Jun 2023 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, June 6, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) today announced that following a review of its</description>
</item>
<item>
<title>Check-Cap Reports First Quarter 2023 Financial Results</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-first-quarter-2023-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-first-quarter-2023-financial-results</guid>
<pubDate>Thu, 11 May 2023 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, May 11, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical stage medical diagnostics company</description>
</item>
<item>
<title>Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-fourth-quarter-and-full-year-2022-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-fourth-quarter-and-full-year-2022-financial-results</guid>
<pubDate>Fri, 31 Mar 2023 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, March 31, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Issues an Update to Shareholders</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-issues-an-update-to-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-issues-an-update-to-shareholders</guid>
<pubDate>Tue, 21 Mar 2023 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, March 21, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-third-quarter-2022-financial-results-and-provides-a-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-third-quarter-2022-financial-results-and-provides-a-corporate-update</guid>
<pubDate>Wed, 30 Nov 2022 05:00:00 GMT</pubDate>
<description>ISFIYA, Israel, Nov. 30, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-second-quarter-2022-financial-results-and-provides-a-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-second-quarter-2022-financial-results-and-provides-a-corporate-update</guid>
<pubDate>Wed, 31 Aug 2022 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, Aug. 31, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-ltd-nasdaq-chek-announces-receipt-of-extension-to-meet-the-nasdaqs-minimum-bid-price-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-ltd-nasdaq-chek-announces-receipt-of-extension-to-meet-the-nasdaqs-minimum-bid-price-requirement</guid>
<pubDate>Thu, 23 Jun 2022 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, June 23, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-first-quarter-2022-financial-results-and-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-first-quarter-2022-financial-results-and-corporate-update</guid>
<pubDate>Wed, 01 Jun 2022 04:00:00 GMT</pubDate>
<description>Company initiated first part of its U.S. pivotal study in early May 2022 ISFIYA, Israel, June 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or</description>
</item>
<item>
<title>Check-Cap Announces Initiation of the U.S. Pivotal Trial</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-initiation-of-the-us-pivotal-trial</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-initiation-of-the-us-pivotal-trial</guid>
<pubDate>Wed, 11 May 2022 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-fourth-quarter-and-full-year-2021-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-fourth-quarter-and-full-year-2021-financial-results</guid>
<pubDate>Thu, 07 Apr 2022 04:00:00 GMT</pubDate>
<description>Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel, April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the</description>
</item>
<item>
<title>Check-Cap Ltd. Announces $10 Million Registered Direct Offering</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-ltd-announces-dollar10-million-registered-direct-offering</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-ltd-announces-dollar10-million-registered-direct-offering</guid>
<pubDate>Tue, 01 Mar 2022 05:00:00 GMT</pubDate>
<description>ISFIYA, Israel, March 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
<item>
<title>Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-fda-approval-of-amended-ide-application-for-pivotal-study-of-c-scan</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-fda-approval-of-amended-ide-application-for-pivotal-study-of-c-scan</guid>
<pubDate>Mon, 07 Feb 2022 05:00:00 GMT</pubDate>
<description>Company anticipates initiation of first part of pivotal study in the March-April 2022 timeframe ISFIYA, Israel, Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd.</description>
</item>
<item>
<title>Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-publication-of-peer-reviewed-article-highlighting-safety-and-patient-satisfaction-data-for-its-colorectal-screening-test-c-scanr</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-announces-publication-of-peer-reviewed-article-highlighting-safety-and-patient-satisfaction-data-for-its-colorectal-screening-test-c-scanr</guid>
<pubDate>Mon, 22 Nov 2021 05:00:00 GMT</pubDate>
<description>Patients who underwent the procedure, as part of the 2019 U.S. pilot study, were significantly more likely to recommend C-Scan test compared to colonoscopy</description>
</item>
<item>
<title>Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update</title>
<link>https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-third-quarter-2021-financial-results-and-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/check-cap-ltd-1/news/check-cap-reports-third-quarter-2021-financial-results-and-corporate-update</guid>
<pubDate>Wed, 03 Nov 2021 04:00:00 GMT</pubDate>
<description>ISFIYA, Israel, Nov. 3, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical</description>
</item>
</channel>
</rss>